Role of th mitochondrial bc₁-complex in the cytotoxic action of diethylstilbestrol-diphosphate toward prostatic carcinompa cellsSCHULZ, P; LINK, T. A; CHAUDHURI, L et al.Cancer research (Baltimore). 1990, Vol 50, Num 16, pp 5008-5012, issn 0008-5472, 5 p.Article

Adrenal steroids in human prostatic cancer cell linesKOH, E; KANAYA, J; NAMIKI, M et al.Archives of andrology. 2001, Vol 46, Num 2, pp 117-125, issn 0148-5016Article

Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostate carcinoma cellsMING-FONG LIN; DAVOLIO, J; GARCIA, R et al.Biochemical and biophysical research communications (Print). 1993, Vol 192, Num 2, pp 413-419, issn 0006-291XArticle

Antiandrogens and 5-alpha reductase inhibition of the proliferation rate in PC3 and DU145 human prostatic cancer cell linesBOLOGNA, M; MUAI; BIORDI, L et al.Current therapeutic research. 1992, Vol 51, Num 6, pp 799-813, issn 0011-393XArticle

Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145DUROCHER, Y; CHAPDELAINE, A; CHEVALIER, S et al.Cancer research (Baltimore). 1989, Vol 49, Num 17, pp 4818-4823, issn 0008-5472Article

Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cellsLE DAI, J; MAIORINO, C. A; GKONOS, P. J et al.Steroids. 1996, Vol 61, Num 9, pp 531-539, issn 0039-128XArticle

13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cellsRAJVIR DAHIYA; BOYLE, B; PARK, H.-D et al.Biochemistry and molecular biology international. 1994, Vol 32, Num 1, pp 1-12, issn 1039-9712Article

The effect of opiates upon prostatic carcinoma cell growthMOON, T. D.Biochemical and biophysical research communications (Print). 1988, Vol 153, Num 2, pp 722-727, issn 0006-291XArticle

Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancerGUDUDURU, Veeresa; HURH, Eunju; DURGAM, Gangadhar G et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 19, pp 4919-4923, issn 0960-894X, 5 p.Article

Clioquinol Independently Targets NF-κB and Lysosome Pathways in Human Cancer CellsHAIJUN YU; LOU, Jessica R; DING, Wei-Qun et al.Anticancer research. 2010, Vol 30, Num 6, pp 2087-2092, issn 0250-7005, 6 p.Article

Modulation of CD99/MIC2 expression of human AHTO-7 osteoblasts by carcinoma cell line-conditioned mediaHAMILTON, Gerhard; MALLINGER, Rudolf; MILLESI, Hanno et al.Anticancer research. 2001, Vol 21, Num 6A, pp 3909-3913, issn 0250-7005Article

Inhibition of the activity of basic 5α-reductase (type 1) detected in DU 145 cells and expressed in insect cellsDELOS, S; IEHLE, C; MARTIN, P.-M et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 48, Num 4, pp 347-352, issn 0960-0760Article

Subtractive cloning of a hybrid human endogenous retrovirus and calbindin gene in teh prostate cell line PC3LIU, A. Y; ABRAHAM, B. A.Cancer research (Baltimore). 1991, Vol 51, Num 15, pp 4107-4110, issn 0008-5472Article

Growth factors in human prostate cancer cells : implications for an improved treatment of prostate cancerKNABBE, C; KELLNER, U; SCHMAHL, M et al.Journal of steroid biochemistry and molecular biology. 1991, Vol 40, Num 1-3, pp 185-192, issn 0960-0760Conference Paper

Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cellsNICOLETTI, Maria Ines; MYERS, Timothy G; FOJO, Tito et al.International journal of oncology. 2001, Vol 18, Num 2, pp 375-381, issn 1019-6439Article

Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stressBARNETT, G; JAKOBSEN, A.-M; TAS, M et al.Cancer research (Baltimore). 2000, Vol 60, Num 11, pp 2850-2857, issn 0008-5472Article

Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cellsRAGO, R. P; BRAZY, P. C; WILDING, G et al.Cancer research (Baltimore). 1992, Vol 52, Num 24, pp 6953-6955, issn 0008-5472Article

Production and response of a human prostatic cancer line to transforming growth factor-like moleculesMACDONALD, A; CHISHOLM, G. D; HABIB, F. K et al.British journal of cancer. 1990, Vol 62, Num 4, pp 579-584, issn 0007-0920, 6 p.Article

Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21^WAF1/CIP1 and C/EBPβ expressions and suppressing NF-KB activationHOUR, Tzyh-Chyuan; JUN CHEN; HUANG, Chao-Yuan et al.The Prostate. 2002, Vol 51, Num 3, pp 211-218, issn 0270-4137Article

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cellsRIPPLE, M. O; HENRY, W. F; RAGO, R. P et al.Journal of the National Cancer Institute. 1997, Vol 89, Num 1, pp 40-48, issn 0027-8874Article

E4, a new monoclonal antibody identifying a human prostatic cell surface antigenNILSSON, S; ESSAND, M; LÖGDAHL, P et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 6, pp 395-403, issn 1084-9785Conference Paper

Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cellsMAKHOV, Peter B; GOLOVINE, Konstantin V; KUTIKOV, Alexander et al.Carcinogenesis (New York. Print). 2011, Vol 32, Num 12, pp 1773-1781, issn 0143-3334, 9 p.Article

Expression of the developmental and oncogenic PAX2 gene in human prostate cancerKHOUBEHI, Bijan; KESSLING, Anna M; ADSHEAD, James M et al.The Journal of urology. 2001, Vol 165, Num 6, pp 2115-2120, issn 0022-5347, 1Article

Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cellsCHUANHAI GUO; GEVERD, Dawn; RAY LIAO et al.The Journal of urology. 2001, Vol 166, Num 2, pp 694-698, issn 0022-5347Article

MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissueSCHUT, I. C; WATERFALL, P. M; ROSS, M et al.BJU international (Papier). 2003, Vol 91, Num 3, pp 278-283, issn 1464-4096, 6 p.Article